Jeffrey Crawford, M.D.

Professor of Medicine, Duke University

Jeffrey Crawford, M.D. is the DSMB Chairman for Study 105 and Study 106.

Dr. Crawford is a Professor of Medicine at Duke University.  He is the Chairman of NCCN guidelines for neutropenia management in the U.S. and was the lead investigator of the U.S. multicenter, randomized trial of Filgrastim (G-CSF, Neupogen), which received approval from Food and Drug Administration in 1991.

© 2020 BeyondSpring Inc. All rights reserved.